Transplanted Heart Cardiomyocytes Reveal Continous Expression of Antiapoptotic Bcl-2 Protein

Transplantation Proceedings

Volumn 39, Issue 9, 2007, Pages 2841-2845

  Nozynski, J ^a   Zakliczynski, M ^a   Zembala Nozynska, E ^a   Konecka Mrowka, D ^a   Nikiel, B ^b   Przybylski, R ^a   Lange, D ^b   Maruszewski, M ^a   Zembala, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

APOPTOSIS; BIOPSY; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MYOCARDIUM; MYOCYTES, CARDIAC; POSTOPERATIVE PERIOD; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES;

EID: 36048986420     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.075     Document Type: Article

References (26)

1. Anversa P., Kajstura J., and Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol 11 (1996) 2451
2. Chen Q.M., and Tu V.C. Apoptosis and heart failure: mechanisms and therapeutic implications. Am J Cardiovasc Drugs 2 (2002) 43
3. Cheng W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J Clin Invest 96 (1995) 2247
4. Fliss H., and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79 (1996) 949
5. James T.N. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Trans Am Clin Climatol Assoc 105 (1993) 145
6. Sharov V.G., Sabbah H.N., Shimoyama H., et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148 (1996) 141
7. Veinot J.P., Gattinger D.A., and Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol 28 (1997) 485
8. Yao M., Keogh A., Spratt P., et al. Elevated Dnase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis?. J Mol Cell Cardiol 28 (1996) 95
9. Kajstura J., Cheng W., Sarangarajan R., et al. Necrocytic and apoptotic myocyte cell death in the aging heart of Fisher 344 rats. Am J Physiol 271 (1996) H1215
10. Teiger E., Than V.D., Richard L., et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. Clin Invest 97 (1996) 2891
11. Bergese S.D., Klenotic S.M., Wakely M.E., et al. Apoptosis in murine cardiac grafts. Transplantation 63 (1997) 320
12. Szabolcs M., Michler R.E., Yang X., et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide syntase. Circulation 94 (1996) 1665
13. Mallat Z., Fornes P., Costagliola R., et al. Age and gender effects on cardiocyte apoptosis in normal human hearts. Gerontol A Biol Sci Med Sci 56 (2001) M719
14. Tanaka M., Nakae S., Terry R.D., et al. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection and graft coronary artery disease. Blood 104 (2004) 3789
15. Suzuki J., Isobe M., Morishita R., et al. Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts. Cardiovasc Res 45 (2000) 783
16. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 9 (1990) 587
17. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440
18. Crow M.T., Mani K., Nam Y.-J., et al. The mitochondrial pathway and cardiac myocyte apoptosis. Circ Res 95 (2004) 957
19. Alter P., Jobmann M., Meyer E., et al. Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis?. An endomyocardial biopsy study. Cardiovasc Pathol 10 (2001) 229
20. Masri S.C., Yamani M.H., Russell M.A., et al. Sustained apoptosis in human cardiac allografts despite histologic resolution of rejction. Transplantation 76 (2003) 859
21. Mailloux A., Bruneel A., Vaubourdolle M., et al. Cyclosporin A but not estradiol can protect endothelial cells against etoposide-induced apoptosis. Endothelium 11 (2004) 141
22. Masters T.N., Fokin A.A., Schaper J., et al. Extending myocardial viability during heart preservation with cyclosporine A. J Card Surg 15 (2000) 392
23. Montero N., Lobaton C.D., Gutierrez-Fernandez S., et al. Calcineurin-independent inhibition of mitochondrial Ca2+ uptake by cyclosporin A. Br J Pharmacol 141 (2004) 263
24. Nakahara C., Nakamura K., Yamanaka N., et al. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor- kappaB activation in human gastric carcinoma cells. Clin Cancer Res 9 (2003) 5409
25. Bulut S., Ozdemir B.H., Alaaddinoglu E.E., et al. Effect of cyclosporin A on apoptosis and expression of p53 and Bcl-2 proteins in the gingiva of renal transplant patients. J Peridontol 76 (2005) 691
26. De Windt L.J., Lim H.W., Wencker D., et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circ Res 86 (2000) 255